(Sharecast News) - Clinical stage biotechnology company PureTech Health announced on Thursday that its affiliate Sonde Health had appointed David Liu as chief executive officer and a member of its board of directors.
PureTech noted that Liu, who spent more than a decade pioneering novel online products with America Online, had served in executive roles across multiple enterprises targeting international markets, including Quartet, a growth-stage enterprise healthcare technology company, and Knewton, where he helped to build a leading global education technology company.
The FTSE 250 firm's chief innovation officer Eric Elenko said: "David's experience guiding companies through significant growth positions him as a valuable addition to Sonde's team as they pioneer a new approach to healthcare."
As of 0830 BST, PureTech shares had inched back 0.39% to 254p.
PureTech (PRTC)25 Apr 2024 10:07
Puretech Health operating losses narrow in 'landmark year'
(Sharecast News) - Biotechnology company Puretech Health said on Thursday that 2023 had been "a landmark year" for the group, making "strong strategic...
